Bioequivalence Study Between SKF101804 Cefixime 200 Milligram (mg)/5 Milliliter (mL) Suspension Versus Cefixime 200 mg/5 mL Suspension Reference Product in Healthy Adult Subjects Under Fasting Conditions
Clinical trial NCT03408392 · COMPLETED
Trial details
- NCT number
- NCT03408392
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-06
- Primary completion
- 2018-03-13
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.